Tesla CFO Says Expects Average Selling Price To Be Above $47K In 2023

-Reuters

-Reuters

Total
0
Shares
Related Posts
Read More

Centers For Medicare & Medicaid Services Approves Transitional Pass-through Reimbursement Status For Harrow’s Iheezo (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% For Ocular Surface Anesthesia

Beginning April 1, 2023, and for the three years thereafter, IHEEZO will be eligible for separate reimbursement outside of the surgical bundled payment in both the Ambulatory Surgery Center (ASC) and Hospital

HROW